Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease ; day:10 ; month:10 ; year:2017 ; pages:1-19
Molecular neurobiology ; (10.10.2017), 1-19
- Keyword
-
Fitness
Sportunterricht
Fitnesstraining
Sportpädagogik
Präventives Training
Gesundheitssport
- Creator
-
Klemann, Cornelius J. H. M.
- Contributor
-
Xicoy, Helena
Poelmans, Geert
Bloem, Bas R.
Martens, Gerard J. M.
Visser, Jasper E.
SpringerLink (Online service)
- DOI
-
10.1007/s12035-017-0775-0
- URN
-
urn:nbn:de:1111-2017111513521
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klemann, Cornelius J. H. M.
- Xicoy, Helena
- Poelmans, Geert
- Bloem, Bas R.
- Martens, Gerard J. M.
- Visser, Jasper E.
- SpringerLink (Online service)
Other Objects (12)
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3